UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7L3UV85 | Voltage-dependent T-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L3VYY8 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L3VM86 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
A0A7L3VUW6 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L3VVF6 | BACE2 secretase (Fragment) |
|
1 | 0 |
|
A0A7L3V4Z2 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L3VUN1 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L3VGK1 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L3V2Q6 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7L3VBZ7 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7L3VCT6 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L3VA76 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L3V7P9 | Angiotensin-converting enzyme (Fragment) |
|
3 | 0 |
|
A0A7L3VVY1 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L3VT49 | ATS1 metalloproteinase (Fragment) |
|
2 | 0 |
|
A0A7L3VZF5 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
A0A7L3VSP2 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7L3VVQ6 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7L3VNX2 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
A0A7L3VE23 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7L3VSB5 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7L3UV23 | Tartrate-resistant acid phosphatase type 5 (Fragment) |
|
1 | 0 |
|
A0A7L3V727 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A7L3V1P3 | KCNKG protein (Fragment) |
|
1 | 0 |
|
A0A7L3VJ05 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024